Get started
NeuroMetrix, Inc.NeuroMetrix, Inc.NeuroMetrix, Inc.

NeuroMetrix, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

NURO chart


Full chart

NURO upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪7.82 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−4.24 USD
Net income (FY)
‪−6.53 M‬ USD
Revenue (FY)
‪5.90 M‬ USD
Shares float
‪1.44 M‬
Beta (1Y)
0.90

Employees


Employees (FY)
26
Change (1Y)
−1 −3.70%
Revenue / Employee (1Y)
‪226.98 K‬ USD
Net income / Employee (1Y)
‪−251.13 K‬ USD

About NeuroMetrix, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Shai N. Gozani
Website
neurometrix.com
Headquarters
Woburn
Founded
1996
FIGI
BBG000BB88M2
NeuroMetrix, Inc. engages in the development and manufacture of diagnostic and therapeutic neurostimulation-based medical devices. Its products include DPNCheck, Quell, and ADVANCE system. It also focuses on the sale of medical equipment and consumables. The company was founded by Shai N. Gozani in June 1996 and is headquartered in Woburn, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

NURO news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of NURO is 3.72 USD — it has decreased by −2.87% in the past 24 hours. Watch NeuroMetrix, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange NeuroMetrix, Inc. stocks are traded under the ticker NURO.
NURO stock has fallen by −7.23% compared to the previous week, the month change is a −7.92% fall, over the last year NeuroMetrix, Inc. has showed a −7.00% decrease.
NURO reached its all-time high on Apr 21, 2006 with the price of 3,796,070.40 USD, and its all-time low was 2.66 USD and was reached on Aug 13, 2024. View more price dynamics on NURO chart.
See other stocks reaching their highest and lowest prices.
NURO stock is 5.49% volatile and has beta coefficient of 0.90. Track NeuroMetrix, Inc. stock price on the chart and check out the list of the most volatile stocks — is NeuroMetrix, Inc. there?
Today NeuroMetrix, Inc. has the market capitalization of ‪7.60 M‬, it has decreased by −0.49% over the last week.
Yes, you can track NeuroMetrix, Inc. financials in yearly and quarterly reports right on TradingView.
NeuroMetrix, Inc. is going to release the next earnings report on Jan 23, 2025. Keep track of upcoming events with our Earnings Calendar.
NURO net income for the last quarter is ‪−1.51 M‬ USD, while the quarter before that showed ‪−1.49 M‬ USD of net income which accounts for −1.36% change. Track more NeuroMetrix, Inc. financial stats to get the full picture.
No, NURO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 9, 2024, the company has 26.00 employees. See our rating of the largest employees — is NeuroMetrix, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NeuroMetrix, Inc. EBITDA is ‪−8.48 M‬ USD, and current EBITDA margin is −120.24%. See more stats in NeuroMetrix, Inc. financial statements.
Like other stocks, NURO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NeuroMetrix, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NeuroMetrix, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NeuroMetrix, Inc. stock shows the sell signal. See more of NeuroMetrix, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.